Arcadia Biosciences, Inc. (RKDA) Aandelenanalyse

Bedrijfsoverzicht

Arcadia Biosciences, Inc. is engaged in the production and marketing of plant-based food and beverage products within the United States market, while simultaneously developing crop improvements specifically focused on wheat to enhance overall farm economics. The company operates within the Consumer Defensive sector, specifically under the Packaged Foods industry classification, which implies a business model focused on providing essential goods that are generally less sensitive to economic downturns than discretionary spending. This enterprise maintains a market capitalization of $2.72 million and generates an annual revenue of $4.86 million, supported by an operational workforce of 8 employees. The combination of a market cap of $2.72 million and annual revenue of $4.86 million indicates that the company functions as a micro-cap entity with a very small scale relative to the broader Packaged Foods industry, suggesting limited diversification and a high degree of dependence on its specific wheat crop improvement technologies and niche product lines.

Financiële gezondheid

The company reported a trailing twelve-month revenue of $4.86 million, yet it recorded a net income of $-2,339,000 and an EBITDA of $-5,218,000, revealing a significant structural gap where operating expenses and losses heavily outweighed total sales. Despite the substantial net loss, the entity demonstrated positive free cash flow of $721,750, which indicates a degree of financial flexibility allowing the company to fund operations or invest in research without immediate reliance on external equity financing or debt issuance. Profitability metrics are constrained by a gross margin of 36.0%, while the operating margin stands at a negative 152.6% and the profit margin is negative 48.1%, indicating that current operational costs and overheads are disproportionately high relative to the revenue generated. The balance sheet displays a conservative stance with total cash holdings of $4.56 million contrasted against zero total debt, eliminating any leverage risk for the organization. This liquidity position is further supported by a current ratio of 3.09, which signifies a robust ability to meet short-term obligations with its liquid assets. Return metrics show a return on equity of -45.1% and a return on assets of -32.7%, reflecting that management effectiveness is currently challenged by the inability to generate returns on the capital invested in the business.

Waarderingsbeoordeling

Valuation multiples for the company present a complex picture, with a trailing P/E ratio of N/A due to negative earnings, and a forward P/E of -1.03 that suggests the market is pricing in an expectation of future earnings normalization or continued losses. The price-to-book ratio is recorded at 0.44, indicating that the market values the company at less than half of its book value, which often signals a deep discount or potential distress in the valuation relative to its net asset position. Alternative valuation metrics such as the price-to-sales ratio of 0.56 and an EV/EBITDA of 0.35 suggest that the stock is priced very low relative to its revenue and enterprise value, potentially compensating for the lack of profitability. Historical price volatility is framed by a 52-week high of $6.71 and a 52-week low of $1.30, placing the current trading price contextually within this wide range and highlighting the asset's sensitivity to market sentiment shifts. The stock exhibits a beta of 0.72, which implies that the share price tends to be less volatile than the broader market, moving at a lower magnitude when the overall market index rises or falls.

Growth & Income

Revenue growth for the trailing twelve-month period stands at -25.9%, while earnings growth is listed as N/A due to the negative net income, meaning there is no traditional earnings expansion to compare against revenue contraction. The company does not distribute dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which indicates that all available cash flow and earnings are retained within the company rather than being distributed to shareholders. Consequently, the firm reinvests its free cash flow of $721,750 and other financial resources back into its core operations, such as crop improvement research in wheat, rather than paying out income to investors. The overall growth and income profile is characterized by negative revenue momentum and a lack of dividend income, relying entirely on capital appreciation potential driven by future operational improvements in its plant-based product lines.